Akso Health Group (AHG) Revenue History
Annual and quarterly revenue from 2015 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AHG Revenue Growth
Revenue Breakdown (FY 2022)
AHG's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
AHG Revenue Analysis (2015–2025)
As of May 8, 2026, Akso Health Group (AHG) generated trailing twelve-month (TTM) revenue of $14.8 million, reflecting explosive growth of +415.8% year-over-year. The most recent quarter (Q4 2025) recorded $3.9 million in revenue, up 0.0% sequentially.
Looking at the longer-term picture, AHG's 5-year compound annual growth rate (CAGR) stands at +16.4%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $107.3 million in 2018.
Revenue diversification analysis shows AHG's business is primarily driven by Interest income (100%). With over half of revenue concentrated in Interest income, the company maintains significant focus in this area while developing other growth vectors.
When compared to Financial Services sector peers including JFIN (+9.0% YoY), QFIN, and LX, AHG has outperformed the peer group in terms of revenue growth. Compare AHG vs JFIN →
AHG Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AHGCurrent | $15M | +415.8% | +16.4% | -1125.4% | |
 JFIN | $5.8B | +9.0% | +21.1% | 21.5% | |
 QFIN | $17.2B | - | - | 43.9% | |
 LX | $14.2B | - | - | 16.1% | |
 FINV | $13.1B | - | - | 19.4% | |
 HCM | $630M | -1.4% | +25.2% | -6.9% |
AHG Historical Revenue Data (2015–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $14.8M | - | $-281,526 | -1.9% | $-166,304,352 | -1125.4% |
| 2024 | $2.4M | - | $122K | 5.1% | $-8,638,040 | -357.8% |
| 2023 | $13.2M | - | $1.3M | 9.6% | $-14,266,853 | -108.2% |
| 2022 | $6.0M | - | $605K | 10.1% | $-3,260,463 | -54.3% |
| 2021 | $1.8M | - | $1.2M | 69.0% | $-27,149,727 | -1547.1% |
| 2020 | $6.9M | - | $6.9M | 100.0% | $-48,105,690 | -695.7% |
| 2019 | $3.7M | - | $3.7M | 100.0% | $-7,189,188 | -194.6% |
| 2018 | $107.3M | - | $98.8M | 92.1% | $75.9M | 70.7% |
| 2017 | $22.9M | - | $17.8M | 77.5% | $9.9M | 43.3% |
| 2016 | $11.9M | - | $9.5M | 80.2% | $4.1M | 34.8% |
See AHG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AHG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AHG vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonAHG — Frequently Asked Questions
Quick answers to the most common questions about buying AHG stock.
Is AHG's revenue growth accelerating or slowing?
AHG revenue is accelerating at +415.8% year-over-year, exceeding the 5-year CAGR of +16.4%. TTM revenue reached $15M. Growth momentum has increased versus prior periods.
What is AHG's long-term revenue growth rate?
Akso Health Group's 5-year revenue CAGR of +16.4% reflects the sustained expansion pattern. Current YoY growth of +415.8% is above this long-term average.
How is AHG's revenue distributed by segment?
AHG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2015-2025 are available for download. Segment mix reveals concentration and diversification trends.